(-)-demecolcine increases expression ISO RGD:1352146 6480464 Demecolcine results in increased expression of MT2A mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1352146 6480464 epigallocatechin gallate inhibits the reaction [IL6 protein results in increased expression of MT2A mRNA], epigallocatechin gallate inhibits the reaction [zinc chloride results in increased expression of MT2A mRNA] CTD PMID:20471814 (-)-epigallocatechin 3-gallate decreases expression ISO RGD:1352146 6480464 epigallocatechin gallate results in decreased expression of MT2A mRNA CTD PMID:20471814 more ... (S)-nicotine multiple interactions ISO RGD:1617617 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of MT2A mRNA CTD PMID:27840820 1,4-phenylenediamine increases expression ISO RGD:1352146 6480464 4-phenylenediamine results in increased expression of MT2A mRNA CTD PMID:16314067 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:1352146 6480464 Dinitrochlorobenzene results in increased expression of MT2A mRNA CTD PMID:20491607 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions ISO RGD:1617617 6480464 [Caffeine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases expression ISO RGD:1617617 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of MT2A mRNA CTD PMID:25380136 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of MT2A mRNA CTD PMID:30723492 1-naphthyl isothiocyanate increases expression ISO RGD:1617617 6480464 1-Naphthylisothiocyanate results in increased expression of MT2 mRNA CTD PMID:27853831 1-naphthyl isothiocyanate multiple interactions ISO RGD:1617617 6480464 pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of MT2 mRNA], PPARA protein affects the reaction [pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of MT2 mRNA]] CTD PMID:27853831 17alpha-ethynylestradiol increases expression ISO RGD:1352146 6480464 Ethinyl Estradiol results in increased expression of MT2A mRNA CTD PMID:23135549 17alpha-ethynylestradiol multiple interactions ISO RGD:1617617 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MT2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:1617617 6480464 Ethinyl Estradiol results in increased expression of MT2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:1352146 6480464 [Ethinyl Estradiol co-treated with Cadmium Chloride] results in increased expression of MT2A mRNA CTD PMID:23135549 17beta-estradiol increases expression ISO RGD:1352146 6480464 Estradiol results in increased expression of MT2A mRNA CTD PMID:16202921 more ... 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of MT2A mRNA CTD PMID:35192832 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of MT2A mRNA CTD PMID:26945725 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with Plant Preparations] results in decreased expression of MT2A mRNA CTD PMID:26945725 17beta-estradiol decreases expression ISO RGD:1352146 6480464 Estradiol results in decreased expression of MT2A mRNA CTD PMID:17982697 , PMID:23019147 17beta-estradiol multiple interactions ISO RGD:1352146 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of MT2A mRNA more ... CTD PMID:12399409 more ... 17beta-hydroxy-5alpha-androstan-3-one decreases expression ISO RGD:1352146 6480464 Dihydrotestosterone results in decreased expression of MT2A mRNA CTD PMID:20945400 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1617617 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1352146 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of MT2A mRNA more ... CTD PMID:19619570 , PMID:23994556 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MT2A mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of MT2A mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1352146 6480464 Tetrachlorodibenzodioxin results in increased expression of MT2A mRNA CTD PMID:11489354 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1617617 6480464 Tetrachlorodibenzodioxin affects the expression of MT2 mRNA CTD PMID:24680724 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1617617 6480464 Tetrachlorodibenzodioxin results in increased expression of MT1E mRNA, Tetrachlorodibenzodioxin results in increased expression of MT2 mRNA CTD PMID:18295293 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1617617 6480464 Tetrachlorodibenzodioxin results in decreased expression of MT1A mRNA, Tetrachlorodibenzodioxin results in decreased expression of MT2 mRNA CTD PMID:15667827 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1617617 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MT2 mRNA more ... CTD PMID:17942748 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of MT2A mRNA CTD PMID:11521753 , PMID:18465118 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1352146 6480464 Tetrachlorodibenzodioxin results in decreased expression of MT2A mRNA CTD PMID:16039398 , PMID:19619570 2,4,6-trinitrotoluene increases expression ISO RGD:1352146 6480464 Trinitrotoluene results in increased expression of MT2A mRNA CTD PMID:11409192 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:1352146 6480464 2 more ... CTD PMID:26705709 2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol increases expression ISO RGD:1352146 6480464 Suloctidil results in increased expression of MT2A mRNA CTD PMID:32661532 2-butoxyethanol increases expression ISO RGD:1617617 6480464 n-butoxyethanol results in increased expression of MT2 mRNA CTD PMID:19812364 2-methylcholine affects expression ISO RGD:1352146 6480464 beta-methylcholine affects the expression of MT2A mRNA CTD PMID:21179406 2-nitrofluorene decreases expression EXP 6480464 2-nitrofluorene results in decreased expression of MT2 mRNA, 2-nitrofluorene results in decreased expression of MT2A mRNA CTD PMID:14600272 , PMID:15890375 2-tert-butylhydroquinone increases expression ISO RGD:1617617 6480464 2-tert-butylhydroquinone results in increased expression of MT2 mRNA CTD PMID:14998373 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23527585 more ... 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:1617617 6480464 [MT2 protein affects the susceptibility to 3 more ... CTD PMID:26770886 3,3',4,4',5-pentachlorobiphenyl affects response to substance ISO RGD:1617617 6480464 MT2 protein affects the susceptibility to 3 more ... CTD PMID:26770886 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1617617 6480464 N-Methyl-3 more ... CTD PMID:15306638 3,7-dihydropurine-6-thione increases expression EXP 6480464 Mercaptopurine results in increased expression of MT2A mRNA CTD PMID:23358152 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1617617 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of MT2 mRNA CTD PMID:16054899 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1352146 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of MT2A mRNA CTD PMID:28628672 3-methylcholanthrene increases expression ISO RGD:1352146 6480464 Methylcholanthrene results in increased expression of MT2A mRNA CTD PMID:23994556 3-methylcholanthrene multiple interactions ISO RGD:1352146 6480464 AHR protein affects the reaction [Methylcholanthrene results in increased expression of MT2A mRNA] more ... CTD PMID:23994556 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of MT2A mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of MT2A mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1352146 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of MT2A mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of MT2A mRNA CTD PMID:36041667 4,4'-sulfonyldiphenol decreases expression ISO RGD:1617617 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of MT2 mRNA CTD PMID:33297965 4,4'-sulfonyldiphenol increases expression ISO RGD:1617617 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of MT2 mRNA CTD PMID:30951980 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one decreases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of MT2 mRNA, 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of MT2A mRNA CTD PMID:14600272 , PMID:15890375 4-hydroxynon-2-enal decreases expression ISO RGD:1617617 6480464 4-hydroxy-2-nonenal results in decreased expression of MT2 mRNA CTD PMID:19191707 5-aza-2'-deoxycytidine affects expression ISO RGD:1352146 6480464 Decitabine affects the expression of MT2A mRNA CTD PMID:23300844 5-aza-2'-deoxycytidine increases expression ISO RGD:1352146 6480464 Decitabine results in increased expression of MT2A mRNA CTD PMID:19151715 6-aminonicotinamide multiple interactions ISO RGD:1617617 6480464 6-Aminonicotinamide promotes the reaction [IL6 protein results in increased expression of MT2 protein] CTD PMID:12898533 6-aminonicotinamide increases expression ISO RGD:1617617 6480464 6-Aminonicotinamide results in increased expression of MT2 protein CTD PMID:12898533 6-aminonicotinamide decreases response to substance ISO RGD:1617617 6480464 MT2 protein results in decreased susceptibility to 6-Aminonicotinamide CTD PMID:11835189 [2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol increases expression ISO RGD:1352146 6480464 Mefloquine results in increased expression of MT2A mRNA CTD PMID:32661532 [2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol multiple interactions ISO RGD:1352146 6480464 MTF1 protein affects the reaction [Mefloquine results in increased expression of MT2A mRNA] CTD PMID:32661532 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of MT2A mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of MT2A mRNA CTD PMID:28959563 acrylamide increases expression ISO RGD:1352146 6480464 Acrylamide results in increased expression of MT2A mRNA CTD PMID:32763439 acrylamide multiple interactions EXP 6480464 [Acrylamide co-treated with aluminum chloride] results in increased expression of MT2A mRNA CTD PMID:25858877 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of MT2A mRNA CTD PMID:25858877 actinomycin D multiple interactions ISO RGD:1352146 6480464 Dactinomycin inhibits the reaction [zinc chloride results in increased expression of MT2A mRNA] CTD PMID:17234632 afimoxifene multiple interactions ISO RGD:1352146 6480464 GPER1 protein affects the reaction [afimoxifene results in increased expression of MT2A mRNA] CTD PMID:19153601 afimoxifene increases expression ISO RGD:1352146 6480464 afimoxifene results in increased expression of MT2A mRNA CTD PMID:19153601 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of MT2A mRNA CTD PMID:15890375 , PMID:25378103 aflatoxin B1 increases expression ISO RGD:1352146 6480464 Aflatoxin B1 results in increased expression of MT2A mRNA CTD PMID:21641981 more ... aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of MT2 mRNA CTD PMID:14600272 aflatoxin B1 multiple interactions ISO RGD:1352146 6480464 gluconic acid inhibits the reaction [Zinc Sulfate promotes the reaction [Aflatoxin B1 results in increased expression of MT2A mRNA]], Zinc Sulfate promotes the reaction [Aflatoxin B1 results in increased expression of MT2A mRNA] CTD PMID:27017951 aldehydo-D-glucose multiple interactions EXP 6480464 N more ... CTD PMID:23056475 aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of MT2A mRNA CTD PMID:23056475 alexidine increases expression ISO RGD:1352146 6480464 alexidine results in increased expression of MT2A mRNA CTD PMID:32661532 amiodarone increases expression ISO RGD:1352146 6480464 Amiodarone results in increased expression of MT2A mRNA CTD PMID:36586010 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MT2A mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of MT2A mRNA CTD PMID:30779732 amphibole asbestos increases expression ISO RGD:1352146 6480464 Asbestos, Amphibole results in increased expression of MT2A protein CTD PMID:20855422 antirheumatic drug decreases expression ISO RGD:1352146 6480464 Antirheumatic Agents results in decreased expression of MT2A mRNA CTD PMID:24449571 arachidonic acid multiple interactions ISO RGD:1352146 6480464 Arachidonic Acid promotes the reaction [Zinc Sulfate results in increased expression of MT2A mRNA] CTD PMID:12566070 aristolochic acid A decreases expression ISO RGD:1352146 6480464 aristolochic acid I results in decreased expression of MT2A mRNA CTD PMID:33212167 arsane decreases expression ISO RGD:1352146 6480464 Arsenic results in decreased expression of MT2A mRNA CTD PMID:17637929 arsane multiple interactions EXP 6480464 [[sodium arsenite results in increased abundance of Arsenic] which co-treated with Zinc deficiency] results in increased expression of MT2A mRNA more ... CTD PMID:31542844 arsane affects expression ISO RGD:1352146 6480464 Arsenic affects the expression of MT2A mRNA CTD PMID:33736254 arsane multiple interactions ISO RGD:1352146 6480464 [Palmitic Acid co-treated with Arsenic] results in increased expression of MT2A mRNA CTD PMID:33736254 arsane affects response to substance ISO RGD:1617617 6480464 MT2 protein affects the susceptibility to Arsenic CTD PMID:10828279 arsane increases expression ISO RGD:1617617 6480464 Arsenic results in increased expression of MT2 mRNA CTD PMID:19654921 arsane increases expression ISO RGD:1352146 6480464 Arsenic results in increased expression of MT2A mRNA CTD PMID:11032763 more ... arsenic atom decreases expression ISO RGD:1352146 6480464 Arsenic results in decreased expression of MT2A mRNA CTD PMID:17637929 arsenic atom affects expression ISO RGD:1352146 6480464 Arsenic affects the expression of MT2A mRNA CTD PMID:33736254 arsenic atom multiple interactions ISO RGD:1352146 6480464 [Palmitic Acid co-treated with Arsenic] results in increased expression of MT2A mRNA CTD PMID:33736254 arsenic atom multiple interactions EXP 6480464 [[sodium arsenite results in increased abundance of Arsenic] which co-treated with Zinc deficiency] results in increased expression of MT2A mRNA more ... CTD PMID:31542844 arsenic atom increases expression ISO RGD:1617617 6480464 Arsenic results in increased expression of MT2 mRNA CTD PMID:19654921 arsenic atom affects response to substance ISO RGD:1617617 6480464 MT2 protein affects the susceptibility to Arsenic CTD PMID:10828279 arsenic atom increases expression ISO RGD:1352146 6480464 Arsenic results in increased expression of MT2A mRNA CTD PMID:11032763 more ... arsenite ion affects expression ISO RGD:1352146 6480464 Arsenites affects the expression of MT2A mRNA CTD PMID:19411561 arsenite(3-) increases expression ISO RGD:1352146 6480464 arsenite metabolite results in increased expression of MT2A mRNA CTD PMID:33129825 arsenite(3-) multiple interactions ISO RGD:1352146 6480464 arsenite promotes the reaction [G3BP1 protein binds to MT2A mRNA] CTD PMID:32406909 arsenite(3-) increases expression ISO RGD:1617617 6480464 arsenite results in increased expression of MT2 mRNA CTD PMID:15894712 arsenite(3-) multiple interactions ISO RGD:1617617 6480464 [arsenite co-treated with Benzo(a)pyrene] results in increased expression of MT2 mRNA CTD PMID:15894712 arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of MT2A mRNA CTD PMID:1493605 arsenous acid multiple interactions ISO RGD:1352146 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MT2A protein] more ... CTD PMID:11678611 more ... arsenous acid decreases expression ISO RGD:1352146 6480464 Arsenic Trioxide results in decreased expression of MT2A mRNA CTD PMID:22521957 arsenous acid decreases response to substance ISO RGD:1352146 6480464 MT2A protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:23664956 arsenous acid increases expression ISO RGD:1352146 6480464 Arsenic Trioxide results in increased expression of MT2A mRNA, Arsenic Trioxide results in increased expression of MT2A protein CTD PMID:11678611 more ... astemizole increases expression ISO RGD:1352146 6480464 Astemizole results in increased expression of MT2A mRNA CTD PMID:32661532 atorvastatin calcium multiple interactions EXP 6480464 Atorvastatin inhibits the reaction [Fructose results in increased expression of MT2A mRNA] CTD PMID:21122807 atrazine multiple interactions ISO RGD:1352146 6480464 Atrazine promotes the reaction [arsenic trioxide results in increased expression of MT2A mRNA] CTD PMID:11678611 atrazine increases expression ISO RGD:1352146 6480464 Atrazine results in increased expression of MT2A mRNA CTD PMID:22378314 avobenzone increases expression ISO RGD:1352146 6480464 avobenzone results in increased expression of MT2A mRNA CTD PMID:31016361 Azaspiracid increases expression ISO RGD:1352146 6480464 azaspiracid results in increased expression of MT2A mRNA CTD PMID:28939011 barium chloride increases expression EXP 6480464 barium chloride results in increased expression of MT2A mRNA CTD PMID:26732703 barium chloride multiple interactions EXP 6480464 Plant Extracts inhibits the reaction [barium chloride results in increased expression of MT2A mRNA] CTD PMID:26732703 benomyl increases expression EXP 6480464 Benomyl results in increased expression of MT2A mRNA CTD PMID:15885261 benzalkonium chloride decreases expression ISO RGD:1617617 6480464 Benzalkonium Compounds results in decreased expression of MT2 mRNA CTD PMID:31199489 benzo[a]pyrene multiple interactions ISO RGD:1352146 6480464 [Benzo(a)pyrene co-treated with dibenzo(a, l)pyrene] results in increased expression of MT2A mRNA CTD PMID:17690111 benzo[a]pyrene affects methylation ISO RGD:1352146 6480464 Benzo(a)pyrene affects the methylation of MT2A promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:1352146 6480464 Benzo(a)pyrene results in increased methylation of MT2A 3' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1617617 6480464 Benzo(a)pyrene results in decreased expression of MT2 mRNA CTD PMID:19770486 benzo[a]pyrene increases expression ISO RGD:1617617 6480464 Benzo(a)pyrene results in increased expression of MT2 mRNA CTD PMID:15894712 more ... benzo[a]pyrene multiple interactions ISO RGD:1617617 6480464 [arsenite co-treated with Benzo(a)pyrene] results in increased expression of MT2 mRNA, [corannulene co-treated with Benzo(a)pyrene] results in decreased expression of MT2 mRNA CTD PMID:15894712 , PMID:32417428 benzo[a]pyrene increases expression ISO RGD:1352146 6480464 Benzo(a)pyrene results in increased expression of MT2A mRNA CTD PMID:21632981 more ... benzo[a]pyrene decreases expression ISO RGD:1352146 6480464 Benzo(a)pyrene results in decreased expression of MT2A mRNA CTD PMID:20064835 , PMID:20106945 benzo[d]isothiazol-3-one increases expression ISO RGD:1352146 6480464 1, 2-benzisothiazoline-3-one results in increased expression of MT2A mRNA CTD PMID:20491607 benzoic acid increases expression ISO RGD:1352146 6480464 Benzoic Acid results in increased expression of MT2A mRNA CTD PMID:20491607 benzyl cinnamate increases expression ISO RGD:1352146 6480464 benzyl cinnamate results in increased expression of MT2A mRNA CTD PMID:20491607 beta-naphthoflavone decreases expression ISO RGD:1352146 6480464 beta-Naphthoflavone results in decreased expression of MT2A mRNA CTD PMID:32858204 bifenthrin increases expression ISO RGD:1617617 6480464 bifenthrin results in increased expression of MT2 mRNA CTD PMID:26071804 biochanin A increases expression ISO RGD:1352146 6480464 biochanin A results in increased expression of MT2A mRNA CTD PMID:10656621 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1617617 6480464 Diethylhexyl Phthalate results in decreased expression of MT2 mRNA CTD PMID:15294341 , PMID:28085963 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1352146 6480464 Diethylhexyl Phthalate results in increased expression of MT2A mRNA CTD PMID:31163220 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1617617 6480464 Diethylhexyl Phthalate results in increased expression of MT2 mRNA, Diethylhexyl Phthalate results in increased expression of MT2 protein CTD PMID:15294341 , PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1617617 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of MT2 mRNA] CTD PMID:19850644 bis(2-ethylhexyl) phthalate affects expression ISO RGD:1617617 6480464 Diethylhexyl Phthalate affects the expression of MT2 mRNA CTD PMID:19850644 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MT2A mRNA CTD PMID:25181051 , PMID:35192832 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of MT2A mRNA CTD PMID:36041667 bisphenol A decreases expression ISO RGD:1617617 6480464 bisphenol A results in decreased expression of MT2 mRNA CTD PMID:29165653 , PMID:33221593 bisphenol A decreases expression ISO RGD:1352146 6480464 bisphenol A results in decreased expression of MT2A mRNA, bisphenol A results in decreased expression of MT2A protein CTD PMID:29718440 , PMID:34186270 bisphenol A affects expression ISO RGD:1352146 6480464 bisphenol A affects the expression of MT2A mRNA CTD PMID:30903817 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MT2A mRNA CTD PMID:30903817 bisphenol A increases expression ISO RGD:1617617 6480464 bisphenol A results in increased expression of MT2 mRNA CTD PMID:27623287 bisphenol F increases expression ISO RGD:1617617 6480464 bisphenol F results in increased expression of MT2 mRNA CTD PMID:30951980 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of MT2A mRNA CTD PMID:36041667 bleomycin A5 increases expression ISO RGD:1352146 6480464 bleomycetin results in increased expression of MT2A mRNA, bleomycetin results in increased expression of MT2A protein CTD PMID:21040473 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of MT2A mRNA CTD PMID:15056800 , PMID:32479839 budesonide multiple interactions ISO RGD:1352146 6480464 Terbutaline affects the reaction [Budesonide results in increased expression of MT2A mRNA] CTD PMID:9973176 budesonide increases expression ISO RGD:1352146 6480464 Budesonide results in increased expression of MT2A mRNA CTD PMID:9973176 buta-1,3-diene increases expression ISO RGD:1617617 6480464 1, 3-butadiene results in increased expression of MT2 mRNA CTD PMID:29038090 C.I. Natural Red 20 multiple interactions ISO RGD:1617617 6480464 shikonin inhibits the reaction [Calcimycin results in increased expression of MT2 mRNA] CTD PMID:25451590 cadmium atom affects transport ISO RGD:1352146 6480464 MT2A promoter polymorphism affects the transport of Cadmium CTD PMID:25157674 cadmium atom affects response to substance ISO RGD:1617617 6480464 MT2 protein affects the susceptibility to Cadmium CTD PMID:7890668 cadmium atom affects abundance ISO RGD:1352146 6480464 MT2A gene SNP affects the abundance of Cadmium CTD PMID:21328412 cadmium atom increases expression ISO RGD:1617617 6480464 Cadmium results in increased expression of MT2 mRNA CTD PMID:10605938 more ... cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of MT2A CTD PMID:17948763 cadmium atom multiple interactions EXP 6480464 [[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with hydroquinone] results in increased expression of MT2A mRNA more ... CTD PMID:16226777 , PMID:33188856 cadmium atom affects binding ISO RGD:1617617 6480464 MT2 protein binds to Cadmium CTD PMID:22001350 cadmium atom multiple interactions ISO RGD:1617617 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MT2 mRNA more ... CTD PMID:16568437 more ... cadmium atom increases expression ISO RGD:1352146 6480464 Cadmium results in increased expression of MT2A mRNA, Cadmium results in increased expression of MT2A protein CTD PMID:11032763 more ... cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of MT2 mRNA more ... CTD PMID:11430474 more ... cadmium atom affects binding ISO RGD:1352146 6480464 Cadmium binds to MT2A protein CTD PMID:15698955 cadmium atom affects expression EXP 6480464 Cadmium affects the expression of MT2A mRNA, Cadmium affects the expression of MT2A protein CTD PMID:12140172 cadmium atom decreases response to substance EXP 6480464 MT2A protein results in decreased susceptibility to Cadmium CTD PMID:17443291 cadmium atom decreases response to substance ISO RGD:1352146 6480464 MT2A protein results in decreased susceptibility to Cadmium CTD PMID:19433272 , PMID:29982767 cadmium atom increases abundance ISO RGD:1352146 6480464 MT2A promoter polymorphism results in increased abundance of Cadmium CTD PMID:20303360 cadmium atom multiple interactions ISO RGD:1352146 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MT2A mRNA more ... CTD PMID:11032763 more ... cadmium atom affects expression ISO RGD:1617617 6480464 Cadmium affects the expression of MT2 mRNA CTD PMID:25294218 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of MT2A more ... CTD PMID:17327699 more ... cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of MT2A mRNA CTD PMID:30606898 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of MT2A mRNA CTD PMID:22110744 , PMID:22457021 cadmium dichloride increases response to substance ISO RGD:1617617 6480464 MT2 gene mutant form results in increased susceptibility to Cadmium Chloride, MT2 protein results in increased susceptibility to Cadmium Chloride CTD PMID:16150881 more ... cadmium dichloride decreases expression ISO RGD:1617617 6480464 Cadmium Chloride results in decreased expression of MT2 protein CTD PMID:23376140 cadmium dichloride increases expression ISO RGD:1617617 6480464 Cadmium Chloride results in increased expression of MT2 more ... CTD PMID:11171528 more ... cadmium dichloride multiple interactions ISO RGD:1617617 6480464 4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [Cadmium Chloride results in increased expression of MT2 protein] more ... CTD PMID:10924798 more ... cadmium dichloride increases expression ISO RGD:1352146 6480464 Cadmium Chloride results in increased expression of MT2A mRNA, Cadmium Chloride results in increased expression of MT2A protein CTD PMID:10403520 more ... cadmium dichloride multiple interactions ISO RGD:1352146 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MT2A mRNA more ... CTD PMID:23135549 more ... cadmium dichloride multiple interactions EXP 6480464 [[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with hydroquinone] results in increased expression of MT2A mRNA more ... CTD PMID:19096765 more ... cadmium dichloride decreases expression ISO RGD:1352146 6480464 Cadmium Chloride results in decreased expression of MT2A mRNA CTD PMID:19426795 cadmium dichloride decreases response to substance EXP 6480464 MT2A protein results in decreased susceptibility to Cadmium Chloride CTD PMID:17443291 cadmium dichloride decreases response to substance ISO RGD:1352146 6480464 MT2A protein results in decreased susceptibility to Cadmium Chloride CTD PMID:16636651 , PMID:7729958 cadmium sulfate multiple interactions ISO RGD:1617617 6480464 cadmium sulfate affects the reaction [MTF1 affects the expression of MT2 mRNA] CTD PMID:16221973 cadmium sulfate increases expression ISO RGD:1352146 6480464 cadmium sulfate results in increased expression of MT2A mRNA CTD PMID:10362023 more ... cadmium sulfate decreases expression ISO RGD:1617617 6480464 cadmium sulfate results in decreased expression of MT2 mRNA CTD PMID:19274763 caffeine multiple interactions ISO RGD:1617617 6480464 [Caffeine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 Calcimycin increases expression ISO RGD:1617617 6480464 Calcimycin results in increased expression of MT2 mRNA CTD PMID:25451590 Calcimycin multiple interactions ISO RGD:1617617 6480464 shikonin inhibits the reaction [Calcimycin results in increased expression of MT2 mRNA] CTD PMID:25451590 cannabidiol increases expression ISO RGD:1617617 6480464 Cannabidiol results in increased expression of MT2 mRNA CTD PMID:21542829 more ... cannabidiol increases expression ISO RGD:1352146 6480464 Cannabidiol results in increased expression of MT2A mRNA CTD PMID:33244087 carbon nanotube increases expression ISO RGD:1617617 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 carbonyl cyanide p-trifluoromethoxyphenylhydrazone decreases expression ISO RGD:1352146 6480464 Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in decreased expression of MT2A mRNA CTD PMID:16039398 carmustine affects response to substance ISO RGD:1352146 6480464 MT2A mRNA affects the susceptibility to Carmustine CTD PMID:16365179 carmustine multiple interactions EXP 6480464 MT2 protein inhibits the reaction [Carmustine results in decreased activity of GSR protein], MT2 protein inhibits the reaction [Carmustine results in increased expression of TNF protein] CTD PMID:18528683 carmustine affects response to substance EXP 6480464 MT2 protein affects the susceptibility to Carmustine CTD PMID:18528683 cerium trichloride multiple interactions ISO RGD:1617617 6480464 cerous chloride promotes the reaction [Zinc binds to MT2 protein] CTD PMID:16204935 cerium trichloride decreases expression ISO RGD:1617617 6480464 cerous chloride results in decreased expression of MT2 mRNA CTD PMID:23573234 cerium trichloride increases expression ISO RGD:1617617 6480464 cerous chloride results in increased expression of MT2 protein CTD PMID:15964310 CGP 52608 multiple interactions ISO RGD:1352146 6480464 CGP 52608 promotes the reaction [RORA protein binds to MT2A gene] CTD PMID:28238834 chloroacetaldehyde affects expression ISO RGD:1352146 6480464 chloroacetaldehyde affects the expression of MT2A mRNA CTD PMID:25596134 chloropicrin decreases expression ISO RGD:1352146 6480464 chloropicrin results in decreased expression of MT2A mRNA CTD PMID:26352163 chloroprene increases expression ISO RGD:1617617 6480464 Chloroprene results in increased expression of MT2 mRNA CTD PMID:23125180 cholesterol multiple interactions ISO RGD:1617617 6480464 [Cholesterol co-treated with 1, 2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of MT2 mRNA CTD PMID:22129739 cholesterol increases expression ISO RGD:1617617 6480464 Cholesterol results in increased expression of MT2 protein CTD PMID:29486218 choline multiple interactions ISO RGD:1617617 6480464 [Dietary Fats co-treated with Choline deficiency] results in increased expression of MT2 mRNA more ... CTD PMID:20938992 , PMID:29246445 chromium atom multiple interactions ISO RGD:1352146 6480464 [Chromium co-treated with Cadmium co-treated with Lead] results in increased expression of MT2A mRNA CTD PMID:11032763 chromium trinitrate increases expression ISO RGD:1352146 6480464 chromium nitrate results in increased expression of MT2A mRNA CTD PMID:20491607 chromium(6+) multiple interactions ISO RGD:1352146 6480464 chromium hexavalent ion inhibits the reaction [Cadmium results in increased expression of MT2A mRNA], chromium hexavalent ion inhibits the reaction [Zinc results in increased expression of MT2A mRNA] CTD PMID:12716893 chrysene increases expression ISO RGD:1617617 6480464 chrysene results in increased expression of MT2 mRNA CTD PMID:26377693 cidofovir anhydrous increases expression ISO RGD:1352146 6480464 Cidofovir results in increased expression of MT2A mRNA CTD PMID:25596134 ciguatoxin CTX1B affects expression ISO RGD:1617617 6480464 Ciguatoxins affects the expression of MT2 mRNA CTD PMID:18353800 cisplatin affects expression ISO RGD:1617617 6480464 Cisplatin affects the expression of MT1E mRNA CTD PMID:21151649 cisplatin increases expression ISO RGD:1352146 6480464 Cisplatin results in increased expression of MT2A mRNA CTD PMID:12680227 , PMID:25596134 cisplatin affects response to substance ISO RGD:1352146 6480464 MT2A protein affects the susceptibility to Cisplatin CTD PMID:2116401 cisplatin increases response to substance ISO RGD:1617617 6480464 MT2 protein results in increased susceptibility to Cisplatin CTD PMID:16150881 cisplatin multiple interactions ISO RGD:1617617 6480464 [IL6 gene mutant form co-treated with 1, 3-dimethylthiourea] inhibits the reaction [Cisplatin results in increased expression of MT2 mRNA] CTD PMID:23384965 cisplatin increases expression ISO RGD:1617617 6480464 Cisplatin results in increased expression of MT2 mRNA CTD PMID:23384965 cisplatin affects expression ISO RGD:1352146 6480464 Cisplatin affects the expression of MT2A mRNA CTD PMID:23300844 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of MT2A mRNA CTD PMID:22023808 cisplatin decreases response to substance ISO RGD:1352146 6480464 MT2A protein results in decreased susceptibility to Cisplatin CTD PMID:16394183 clofibrate increases expression ISO RGD:1617617 6480464 Clofibrate results in increased expression of MT2 mRNA CTD PMID:11356909 , PMID:23811191 clofibrate decreases expression ISO RGD:1617617 6480464 Clofibrate results in decreased expression of MT2 mRNA CTD PMID:17585979 clofibrate multiple interactions ISO RGD:1617617 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of MT2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MT2 mRNA] CTD PMID:17585979 cobalt atom increases expression ISO RGD:1352146 6480464 Cobalt results in increased expression of MT2A mRNA CTD PMID:14971665 cobalt dichloride increases expression EXP 6480464 cobaltous chloride deficiency results in increased expression of MT2A mRNA, cobaltous chloride results in increased expression of MT2A mRNA CTD PMID:17706837 more ... cobalt dichloride increases expression ISO RGD:1352146 6480464 cobaltous chloride results in increased expression of MT2A mRNA CTD PMID:19376846 , PMID:22941251 cobalt dichloride multiple interactions EXP 6480464 [Oxygen deficiency co-treated with cobaltous chloride] results in increased expression of MT2A mRNA CTD PMID:19278353 cobalt(2+) sulfate increases expression ISO RGD:1352146 6480464 cobalt sulfate results in increased expression of MT2A mRNA CTD PMID:10362023 copper atom multiple interactions EXP 6480464 [Copper co-treated with Dietary Sucrose] results in decreased expression of MT2A mRNA CTD PMID:26033743 copper atom increases expression EXP 6480464 Copper results in increased expression of MT2A mRNA CTD PMID:30556269 copper atom increases expression ISO RGD:1352146 6480464 Copper results in increased expression of MT2A mRNA CTD PMID:17409696 , PMID:2830259 copper atom affects response to substance ISO RGD:1617617 6480464 MT2 affects the susceptibility to Copper CTD PMID:16629173 copper atom multiple interactions ISO RGD:1617617 6480464 [diamsar chelate results in decreased abundance of Copper] which affects the expression of MT2 mRNA more ... CTD PMID:14627437 more ... copper atom increases expression ISO RGD:1617617 6480464 Copper results in increased expression of MT2 mRNA, Copper results in increased expression of MT2 protein CTD PMID:16629173 more ... copper atom affects expression EXP 6480464 Copper affects the expression of MT2A mRNA, Copper affects the expression of MT2A protein CTD PMID:12140172 copper atom multiple interactions ISO RGD:1352146 6480464 [NSC 689534 binds to Copper] which results in increased expression of MT2A mRNA more ... CTD PMID:16629173 more ... copper(0) multiple interactions EXP 6480464 [Copper co-treated with Dietary Sucrose] results in decreased expression of MT2A mRNA CTD PMID:26033743 copper(0) increases expression EXP 6480464 Copper results in increased expression of MT2A mRNA CTD PMID:30556269 copper(0) increases expression ISO RGD:1352146 6480464 Copper results in increased expression of MT2A mRNA CTD PMID:17409696 , PMID:2830259 copper(0) affects response to substance ISO RGD:1617617 6480464 MT2 affects the susceptibility to Copper CTD PMID:16629173 copper(0) multiple interactions ISO RGD:1617617 6480464 [diamsar chelate results in decreased abundance of Copper] which affects the expression of MT2 mRNA more ... CTD PMID:14627437 more ... copper(0) increases expression ISO RGD:1617617 6480464 Copper results in increased expression of MT2 mRNA, Copper results in increased expression of MT2 protein CTD PMID:16629173 more ... copper(0) affects expression EXP 6480464 Copper affects the expression of MT2A mRNA, Copper affects the expression of MT2A protein CTD PMID:12140172 copper(0) multiple interactions ISO RGD:1352146 6480464 [NSC 689534 binds to Copper] which results in increased expression of MT2A mRNA more ... CTD PMID:16629173 more ... copper(II) chloride affects expression ISO RGD:1352146 6480464 cupric chloride affects the expression of MT2A mRNA CTD PMID:20945374 copper(II) chloride multiple interactions ISO RGD:1352146 6480464 cupric chloride promotes the reaction [Disulfiram results in increased expression of MT2A mRNA] CTD PMID:19789329 copper(II) chloride increases expression ISO RGD:1352146 6480464 cupric chloride results in increased expression of MT2A mRNA CTD PMID:17211630 , PMID:17409708 copper(II) chloride increases expression EXP 6480464 cupric chloride results in increased expression of MT2A mRNA CTD PMID:23174565 copper(II) sulfate increases expression ISO RGD:1352146 6480464 Copper Sulfate results in increased expression of MT2A mRNA CTD PMID:10362023 more ... coumarin increases expression EXP 6480464 coumarin results in increased expression of MT2A mRNA CTD PMID:18480146 crocidolite asbestos affects expression ISO RGD:1352146 6480464 Asbestos, Crocidolite affects the expression of MT2A mRNA CTD PMID:25757056 CU-O LINKAGE increases expression ISO RGD:1352146 6480464 cupric oxide results in increased expression of MT2A mRNA CTD PMID:22077320 more ... Cuprizon increases expression ISO RGD:1617617 6480464 Cuprizone results in increased expression of MT2 protein CTD PMID:15971002 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of MT2A mRNA CTD PMID:27523638 curcumin increases expression EXP 6480464 Curcumin results in increased expression of MT2A mRNA CTD PMID:20229497 curcumin multiple interactions EXP 6480464 Curcumin affects the reaction [Mercuric Chloride results in increased expression of MT2A mRNA] CTD PMID:20229497 cyclosporin A increases expression ISO RGD:1352146 6480464 Cyclosporine results in increased expression of MT2A mRNA CTD PMID:20106945 more ... cypermethrin increases expression ISO RGD:1617617 6480464 cypermethrin results in increased expression of MT2 mRNA CTD PMID:21142847 cypermethrin decreases expression ISO RGD:1617617 6480464 cypermethrin results in decreased expression of MT2 mRNA CTD PMID:29020013 cyproconazole increases expression ISO RGD:1617617 6480464 cyproconazole results in increased expression of MT2 mRNA CTD PMID:22334560 , PMID:23970803 cytarabine decreases expression ISO RGD:1352146 6480464 Cytarabine results in decreased expression of MT2A mRNA CTD PMID:21198554 D-gluconic acid multiple interactions ISO RGD:1352146 6480464 gluconic acid inhibits the reaction [Zinc Sulfate promotes the reaction [Aflatoxin B1 results in increased expression of MT2A mRNA]] CTD PMID:27017951 D-glucose multiple interactions EXP 6480464 N more ... CTD PMID:23056475 D-glucose increases expression EXP 6480464 Glucose results in increased expression of MT2A mRNA CTD PMID:23056475 daidzein increases expression ISO RGD:1352146 6480464 daidzein results in increased expression of MT2A mRNA CTD PMID:10656621 DDE increases expression EXP 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of MT2A mRNA CTD PMID:15885261 DDT decreases expression ISO RGD:1352146 6480464 DDT results in decreased expression of MT2A mRNA CTD PMID:25014179 DDT multiple interactions ISO RGD:1352146 6480464 MT2A protein inhibits the reaction [DDT results in decreased expression of HSD17B1 mRNA] CTD PMID:12858341 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of MT2A mRNA CTD PMID:23640034 deguelin increases expression ISO RGD:1352146 6480464 deguelin results in increased expression of MT2A mRNA CTD PMID:33512557 deoxycholic acid increases expression ISO RGD:1352146 6480464 Deoxycholic Acid results in increased expression of MT2A mRNA CTD PMID:32661532 deoxycholic acid multiple interactions ISO RGD:1352146 6480464 MTF1 protein affects the reaction [Deoxycholic Acid results in increased expression of MT2A mRNA] CTD PMID:32661532 desferrioxamine B multiple interactions ISO RGD:1352146 6480464 [Deferoxamine results in decreased abundance of Iron] which results in increased expression of MT2A mRNA CTD PMID:12393473 dexamethasone multiple interactions ISO RGD:1352146 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of MT2A mRNA more ... CTD PMID:23994556 , PMID:28628672 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of MT2A mRNA CTD PMID:2771874 dexamethasone increases expression ISO RGD:1617617 6480464 Dexamethasone results in increased expression of MT2 mRNA CTD PMID:22733784 more ... dexamethasone increases expression ISO RGD:1352146 6480464 Dexamethasone results in increased expression of MT2A mRNA CTD PMID:23994556 more ... dexamethasone multiple interactions ISO RGD:1617617 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of MT2 mRNA CTD PMID:16054899 dextran sulfate increases expression ISO RGD:1617617 6480464 Dextran Sulfate results in increased expression of MT2 mRNA CTD PMID:35093514 diarsenic trioxide increases expression ISO RGD:1352146 6480464 Arsenic Trioxide results in increased expression of MT2A mRNA, Arsenic Trioxide results in increased expression of MT2A protein CTD PMID:11678611 more ... diarsenic trioxide decreases response to substance ISO RGD:1352146 6480464 MT2A protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:23664956 diarsenic trioxide multiple interactions ISO RGD:1352146 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MT2A protein] more ... CTD PMID:11678611 more ... diarsenic trioxide decreases expression ISO RGD:1352146 6480464 Arsenic Trioxide results in decreased expression of MT2A mRNA CTD PMID:22521957 dibenzo[a,l]pyrene multiple interactions ISO RGD:1352146 6480464 [Benzo(a)pyrene co-treated with dibenzo(a, l)pyrene] results in increased expression of MT2A mRNA CTD PMID:17690111 dichloroacetic acid decreases expression ISO RGD:1617617 6480464 Dichloroacetic Acid results in decreased expression of MT2 mRNA CTD PMID:28962523 dichloromethane multiple interactions ISO RGD:1617617 6480464 [[Particulate Matter co-treated with Methylene Chloride] results in increased abundance of Polycyclic Aromatic Hydrocarbons] which affects the expression of MT2 mRNA CTD PMID:29335169 diclofenac increases expression ISO RGD:1617617 6480464 Diclofenac results in increased expression of MT2 mRNA CTD PMID:26934552 diethyl maleate increases expression ISO RGD:1352146 6480464 diethyl maleate results in increased expression of MT2A mRNA CTD PMID:20491607 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of MT2A mRNA CTD PMID:15890375 dihydroxyacetone decreases expression ISO RGD:1352146 6480464 Dihydroxyacetone results in decreased expression of MT2A mRNA CTD PMID:32506039 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of MT2A mRNA, Oxygen results in increased expression of MT2A mRNA CTD PMID:15680347 more ... dioxygen multiple interactions ISO RGD:1617617 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MT2 mRNA CTD PMID:30529165 dioxygen increases expression ISO RGD:1352146 6480464 Oxygen deficiency results in increased expression of MT2A mRNA CTD PMID:17914565 more ... dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MT2A mRNA, [Oxygen deficiency co-treated with cobaltous chloride] results in increased expression of MT2A mRNA CTD PMID:19278353 , PMID:33729688 diphenylcyclopropenone increases expression ISO RGD:1352146 6480464 diphenylcyclopropenone results in increased expression of MT2A mRNA CTD PMID:20491607 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate increases expression ISO RGD:1352146 6480464 Antimony Potassium Tartrate results in increased expression of MT2A mRNA CTD PMID:28713220 diprotium oxide multiple interactions ISO RGD:1617617 6480464 [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which affects the expression of MT2 mRNA CTD PMID:29335169 diquat multiple interactions ISO RGD:1617617 6480464 PROP1 protein affects the reaction [Diquat results in decreased expression of MT2 mRNA] CTD PMID:20826540 diquat decreases expression ISO RGD:1617617 6480464 Diquat results in decreased expression of MT2 mRNA CTD PMID:20826540 disulfiram increases expression ISO RGD:1352146 6480464 Disulfiram results in increased expression of MT2A mRNA CTD PMID:19789329 , PMID:32661532 disulfiram multiple interactions ISO RGD:1352146 6480464 cupric chloride promotes the reaction [Disulfiram results in increased expression of MT2A mRNA], MTF1 protein affects the reaction [Disulfiram results in increased expression of MT2A mRNA] CTD PMID:19789329 , PMID:32661532 dopamine multiple interactions ISO RGD:1617617 6480464 [MT1 gene mutant form co-treated with MT2 gene mutant form co-treated with Mercuric Chloride] results in decreased abundance of Dopamine CTD PMID:18226494 dorsomorphin multiple interactions ISO RGD:1352146 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases response to substance ISO RGD:1352146 6480464 MT2A protein results in decreased susceptibility to Doxorubicin CTD PMID:11309296 doxorubicin increases expression ISO RGD:1617617 6480464 Doxorubicin results in increased expression of MT2 mRNA CTD PMID:28608983 doxorubicin decreases expression ISO RGD:1352146 6480464 Doxorubicin results in decreased expression of MT2A mRNA CTD PMID:29803840 doxorubicin decreases response to substance ISO RGD:1617617 6480464 MT2 protein results in decreased susceptibility to Doxorubicin, MT2A protein results in decreased susceptibility to Doxorubicin CTD PMID:16144979 more ... doxorubicin multiple interactions ISO RGD:1617617 6480464 [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of ADCY7 mRNA more ... CTD PMID:16144979 more ... doxorubicin multiple interactions ISO RGD:1352146 6480464 [Doxorubicin co-treated with pluronic block copolymer p85] results in increased expression of MT2A mRNA CTD PMID:16579640 doxorubicin increases expression ISO RGD:1352146 6480464 Doxorubicin results in increased expression of MT2A mRNA CTD PMID:16579640 doxycycline multiple interactions ISO RGD:1617617 6480464 Doxycycline inhibits the reaction [Isoproterenol results in increased expression of MT2 mRNA] CTD PMID:18089841 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of MT2A mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:1352146 6480464 entinostat results in increased expression of MT2A mRNA CTD PMID:27188386 , PMID:32870474 epoxiconazole increases expression ISO RGD:1617617 6480464 epoxiconazole results in increased expression of MT2 mRNA CTD PMID:22334560 ethanol increases expression EXP 6480464 Ethanol results in increased expression of MT2A mRNA, Ethanol results in increased expression of MT2A protein CTD PMID:15475485 , PMID:17637929 ethanol affects expression ISO RGD:1617617 6480464 Ethanol affects the expression of MT2 mRNA CTD PMID:30319688 ethanol increases expression ISO RGD:1617617 6480464 Ethanol results in increased expression of MT2 mRNA CTD PMID:12658104 more ... ethanol multiple interactions EXP 6480464 LEPR gene mutant form inhibits the reaction [Ethanol results in increased expression of MT2A mRNA] CTD PMID:15475485 EUK-134 multiple interactions EXP 6480464 Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in increased expression of MT2A mRNA]]] more ... CTD PMID:25724285 farnesal increases expression ISO RGD:1352146 6480464 farnesal results in increased expression of MT2A mRNA CTD PMID:20491607 ferric ammonium citrate multiple interactions ISO RGD:1352146 6480464 [ferric ammonium citrate results in decreased abundance of Iron] which results in increased expression of MT2A mRNA CTD PMID:12393473 fluorescein 5-isothiocyanate increases expression ISO RGD:1352146 6480464 Fluorescein-5-isothiocyanate results in increased expression of MT2A mRNA CTD PMID:20491607 flutamide increases expression EXP 6480464 Flutamide results in increased expression of MT2A mRNA CTD PMID:15885261 folic acid multiple interactions ISO RGD:1617617 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MT2 mRNA, Folic Acid inhibits the reaction [Doxorubicin results in increased expression of MT2 mRNA] CTD PMID:20938992 , PMID:28608983 fructose multiple interactions EXP 6480464 Atorvastatin inhibits the reaction [Fructose results in increased expression of MT2A mRNA] CTD PMID:21122807 fructose increases expression EXP 6480464 Fructose results in increased expression of MT2A mRNA CTD PMID:21122807 fumonisin B1 decreases expression ISO RGD:1617617 6480464 fumonisin B1 results in decreased expression of MT2 mRNA CTD PMID:16221962 furan increases expression EXP 6480464 furan results in increased expression of MT2A mRNA CTD PMID:26194646 gefitinib multiple interactions ISO RGD:1617617 6480464 [Buthionine Sulfoximine co-treated with Gefitinib] results in increased expression of MT2 mRNA CTD PMID:32741899 genistein increases expression ISO RGD:1352146 6480464 Genistein results in increased expression of MT2A mRNA CTD PMID:10656621 genistein 7-O-beta-D-glucoside increases expression ISO RGD:1352146 6480464 genistin analog results in increased expression of MT2A mRNA CTD PMID:16719502 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of MT2A mRNA CTD PMID:22061828 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of MT2A mRNA CTD PMID:33387578 glafenine increases expression EXP 6480464 Glafenine results in increased expression of MT2A mRNA CTD PMID:24136188 glucose increases expression EXP 6480464 Glucose results in increased expression of MT2A mRNA CTD PMID:23056475 glucose multiple interactions EXP 6480464 N more ... CTD PMID:23056475 glutathione multiple interactions ISO RGD:1617617 6480464 [MT1 protein co-treated with MT2 protein] affects the reaction [Glutathione affects the susceptibility to Doxorubicin] CTD PMID:20600803 glycerol increases expression ISO RGD:1352146 6480464 Glycerol results in increased expression of MT2A mRNA CTD PMID:20491607 glyphosate multiple interactions EXP 6480464 Quercetin inhibits the reaction [glyphosate results in increased expression of MT2A mRNA] CTD PMID:30821249 glyphosate increases expression EXP 6480464 glyphosate results in increased expression of MT2A mRNA CTD PMID:30821249 gold atom increases expression ISO RGD:1352146 6480464 Gold results in increased expression of MT2A mRNA CTD PMID:25523186 gold(0) increases expression ISO RGD:1352146 6480464 Gold results in increased expression of MT2A mRNA CTD PMID:25523186 graphene oxide increases expression ISO RGD:1617617 6480464 graphene oxide results in increased expression of MT2 mRNA CTD PMID:33227293 hemin multiple interactions ISO RGD:1352146 6480464 [Hemin results in decreased abundance of Iron] which results in increased expression of MT2A mRNA CTD PMID:12393473 hexadecanoic acid decreases expression ISO RGD:1352146 6480464 Palmitic Acid results in decreased expression of MT2A mRNA CTD PMID:17658692 hexadecanoic acid multiple interactions ISO RGD:1352146 6480464 [Palmitic Acid co-treated with Arsenic] results in increased expression of MT2A mRNA CTD PMID:33736254 hexadecanoic acid multiple interactions EXP 6480464 [Oleic Acid co-treated with Palmitic Acid] results in increased expression of MT2A mRNA CTD PMID:26854922 hydrogen peroxide increases expression ISO RGD:1352146 6480464 Hydrogen Peroxide results in increased expression of MT2A mRNA CTD PMID:12414654 hydrogen peroxide multiple interactions ISO RGD:1617617 6480464 [ferric nitrilotriacetate co-treated with Hydrogen Peroxide] inhibits the reaction [MT2 protein binds to Cadmium] more ... CTD PMID:22001350 , PMID:22914987 hydrogen peroxide increases expression ISO RGD:1617617 6480464 Hydrogen Peroxide results in increased expression of MT1E mRNA more ... CTD PMID:16972253 , PMID:22914987 hydrogen peroxide affects expression ISO RGD:1352146 6480464 Hydrogen Peroxide affects the expression of MT2A mRNA CTD PMID:21179406 hydrogen peroxide multiple interactions ISO RGD:1352146 6480464 MT2A protein inhibits the reaction [Hydrogen Peroxide results in increased abundance of Reactive Oxygen Species] CTD PMID:19433272 hydroquinone multiple interactions EXP 6480464 [[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with hydroquinone] results in increased expression of MT2A mRNA more ... CTD PMID:33188856 hydroquinone increases expression EXP 6480464 hydroquinone results in increased expression of MT2A mRNA CTD PMID:33188856 hydroxycitronellal increases expression ISO RGD:1352146 6480464 hydroxycitronellal results in increased expression of MT2A mRNA CTD PMID:20491607 ifosfamide increases expression ISO RGD:1352146 6480464 Ifosfamide results in increased expression of MT2A mRNA CTD PMID:25596134 indirubin-3'-monoxime multiple interactions ISO RGD:1352146 6480464 [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of MT2A mRNA CTD PMID:18958680 indometacin multiple interactions ISO RGD:1352146 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of MT2A mRNA CTD PMID:28628672 iron atom multiple interactions ISO RGD:1352146 6480464 [Deferoxamine results in decreased abundance of Iron] which results in increased expression of MT2A mRNA more ... CTD PMID:12393473 iron atom affects abundance ISO RGD:1352146 6480464 MT2A gene SNP affects the abundance of Iron CTD PMID:21328412 iron atom increases expression ISO RGD:1617617 6480464 Iron deficiency results in increased expression of MT2 mRNA CTD PMID:24089420 iron atom multiple interactions EXP 6480464 [Zinc co-treated with Iron] results in increased expression of and affects the localization of MT2A protein, Iron results in increased expression of and affects the localization of MT2A protein CTD PMID:17241390 iron atom increases expression EXP 6480464 Iron deficiency results in increased expression of MT2A mRNA CTD PMID:16629162 iron trichloride decreases expression ISO RGD:1352146 6480464 ferric chloride results in decreased expression of MT2A mRNA CTD PMID:26378417 iron(0) increases expression ISO RGD:1617617 6480464 Iron deficiency results in increased expression of MT2 mRNA CTD PMID:24089420 iron(0) affects abundance ISO RGD:1352146 6480464 MT2A gene SNP affects the abundance of Iron CTD PMID:21328412 iron(0) multiple interactions ISO RGD:1352146 6480464 [Deferoxamine results in decreased abundance of Iron] which results in increased expression of MT2A mRNA more ... CTD PMID:12393473 iron(0) multiple interactions EXP 6480464 [Zinc co-treated with Iron] results in increased expression of and affects the localization of MT2A protein, Iron results in increased expression of and affects the localization of MT2A protein CTD PMID:17241390 iron(0) increases expression EXP 6480464 Iron deficiency results in increased expression of MT2A mRNA CTD PMID:16629162 iron(2+) sulfate (anhydrous) multiple interactions EXP 6480464 [Zinc Sulfate co-treated with ferrous sulfate] results in increased expression of and affects the localization of MT2A protein, ferrous sulfate results in increased expression of and affects the localization of MT2A protein CTD PMID:17241390 iron(III) nitrilotriacetate multiple interactions ISO RGD:1617617 6480464 [ferric nitrilotriacetate co-treated with Hydrogen Peroxide] inhibits the reaction [MT2 protein binds to Cadmium] CTD PMID:22001350 isobutanol multiple interactions ISO RGD:1352146 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MT2A mRNA CTD PMID:29432896 isoprenaline multiple interactions ISO RGD:1617617 6480464 Doxycycline inhibits the reaction [Isoproterenol results in increased expression of MT2 mRNA] CTD PMID:18089841 isoprenaline increases expression ISO RGD:1617617 6480464 Isoproterenol results in increased expression of MT2 mRNA CTD PMID:18089841 , PMID:20003209 ivermectin decreases expression ISO RGD:1352146 6480464 Ivermectin results in decreased expression of MT2A protein CTD PMID:32959892 kaempferol increases expression ISO RGD:1352146 6480464 kaempferol results in increased expression of MT2A mRNA CTD PMID:10656621 kainic acid decreases response to substance ISO RGD:1617617 6480464 MT2 protein results in decreased susceptibility to Kainic Acid CTD PMID:10947810 L-methionine multiple interactions ISO RGD:1617617 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MT2 mRNA CTD PMID:20938992 lead diacetate multiple interactions EXP 6480464 [lead acetate co-treated with Cadmium Chloride] results in increased expression of MT2A mRNA more ... CTD PMID:19096765 more ... lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of MT2A mRNA CTD PMID:33862172 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of MT2A mRNA CTD PMID:22641619 more ... lead diacetate decreases response to substance ISO RGD:1617617 6480464 MT2 results in decreased susceptibility to lead acetate CTD PMID:20600549 lead diacetate increases expression ISO RGD:1617617 6480464 lead acetate results in increased expression of MT2 mRNA CTD PMID:21335049 , PMID:30623991 lead diacetate increases expression ISO RGD:1352146 6480464 lead acetate results in increased expression of MT2A mRNA CTD PMID:22839698 lead nitrate decreases response to substance ISO RGD:1617617 6480464 MT2 results in decreased susceptibility to lead nitrate CTD PMID:11891201 lead nitrate multiple interactions ISO RGD:1617617 6480464 lead nitrate affects the reaction [CASP7 affects the expression of MT2 mRNA] more ... CTD PMID:11891201 lead(0) affects abundance ISO RGD:1352146 6480464 MT2A gene SNP affects the abundance of Lead CTD PMID:22005883 lead(0) increases response to substance ISO RGD:1352146 6480464 MT2A gene SNP results in increased susceptibility to Lead CTD PMID:32340109 lead(0) increases expression ISO RGD:1352146 6480464 Lead results in increased expression of MT2A mRNA CTD PMID:11032763 , PMID:34189835 lead(0) multiple interactions ISO RGD:1352146 6480464 [Chromium co-treated with Cadmium co-treated with Lead] results in increased expression of MT2A mRNA CTD PMID:11032763 lead(2+) affects abundance ISO RGD:1352146 6480464 MT2A gene SNP affects the abundance of Lead CTD PMID:22005883 lead(2+) increases response to substance ISO RGD:1352146 6480464 MT2A gene SNP results in increased susceptibility to Lead CTD PMID:32340109 lead(2+) multiple interactions ISO RGD:1352146 6480464 [Chromium co-treated with Cadmium co-treated with Lead] results in increased expression of MT2A mRNA CTD PMID:11032763 lead(2+) increases expression ISO RGD:1352146 6480464 Lead results in increased expression of MT2A mRNA CTD PMID:11032763 , PMID:34189835 lead(II) chloride increases expression ISO RGD:1617617 6480464 lead chloride results in increased expression of MT2 mRNA CTD PMID:23503628 lipopolysaccharide multiple interactions ISO RGD:1617617 6480464 Indirubin E804 inhibits the reaction [Lipopolysaccharides results in increased expression of MT2 mRNA] more ... CTD PMID:11772408 , PMID:23107598 lipopolysaccharide increases expression ISO RGD:1352146 6480464 Lipopolysaccharides results in increased expression of MT2A mRNA CTD PMID:35811015 , PMID:9138684 lipopolysaccharide multiple interactions ISO RGD:1352146 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of MT2A mRNA more ... CTD PMID:35811015 more ... lipopolysaccharide increases expression ISO RGD:1617617 6480464 Lipopolysaccharides results in increased expression of MT2 mRNA CTD PMID:17321000 more ... lipopolysaccharide decreases expression ISO RGD:1617617 6480464 Lipopolysaccharides results in decreased expression of MT2 mRNA CTD PMID:15919760 lithocholic acid increases expression EXP 6480464 Lithocholic Acid results in increased expression of MT2A mRNA CTD PMID:21311750 LY294002 multiple interactions ISO RGD:1352146 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Zinc results in increased expression of MT2A mRNA] CTD PMID:17363595 LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [MT2A protein inhibits the reaction [Tunicamycin results in decreased phosphorylation of AKT1 protein]] CTD PMID:24680926 manganese atom multiple interactions ISO RGD:1617617 6480464 [MT2 protein affects the susceptibility to 3 more ... CTD PMID:26770886 manganese(0) multiple interactions ISO RGD:1617617 6480464 [MT2 protein affects the susceptibility to 3 more ... CTD PMID:26770886 mefloquine multiple interactions ISO RGD:1352146 6480464 MTF1 protein affects the reaction [Mefloquine results in increased expression of MT2A mRNA] CTD PMID:32661532 mefloquine increases expression ISO RGD:1352146 6480464 Mefloquine results in increased expression of MT2A mRNA CTD PMID:32661532 melatonin multiple interactions EXP 6480464 Melatonin promotes the reaction [lead acetate results in increased expression of MT2A mRNA] CTD PMID:25601058 menadione increases expression ISO RGD:1352146 6480464 Vitamin K 3 results in increased expression of MT2A mRNA CTD PMID:12414654 mercaptopurine increases expression EXP 6480464 Mercaptopurine results in increased expression of MT2A mRNA CTD PMID:23358152 Mercuric oxide decreases response to substance ISO RGD:1617617 6480464 MT2 results in decreased susceptibility to mercuric oxide CTD PMID:14692620 more ... mercury atom affects abundance ISO RGD:1352146 6480464 MT2A gene SNP affects the abundance of Mercury CTD PMID:22233731 mercury atom affects response to substance ISO RGD:1352146 6480464 MT2A gene polymorphism affects the susceptibility to Mercury CTD PMID:23827881 mercury atom increases expression EXP 6480464 Mercury results in increased expression of MT2A mRNA CTD PMID:2771874 more ... mercury atom multiple interactions ISO RGD:1352146 6480464 [MT1M gene polymorphism co-treated with MT2A gene polymorphism] affects the susceptibility to Mercury CTD PMID:23827881 mercury atom affects binding ISO RGD:1617617 6480464 Mercury binds to MT2 protein CTD PMID:15603537 mercury atom increases expression ISO RGD:1617617 6480464 Mercury results in increased expression of MT2 mRNA, Mercury results in increased expression of MT2 protein CTD PMID:15138662 more ... mercury atom multiple interactions ISO RGD:1617617 6480464 [MT1 co-treated with MT2] affects the susceptibility to Mercury, [MT3 protein affects the susceptibility to Mercury] which affects the expression of MT2 mRNA CTD PMID:22008530 , PMID:30103553 mercury atom increases response to substance ISO RGD:1617617 6480464 MT2 gene mutant form results in increased susceptibility to Mercury CTD PMID:15782327 mercury dibromide increases expression ISO RGD:1352146 6480464 mercuric bromide results in increased expression of MT2A mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1352146 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MT2A mRNA CTD PMID:27188386 mercury dichloride increases expression ISO RGD:1352146 6480464 Mercuric Chloride results in increased expression of MT2A mRNA CTD PMID:10362023 , PMID:9138684 mercury dichloride increases expression ISO RGD:1617617 6480464 Mercuric Chloride results in increased expression of MT2 mRNA CTD PMID:20450053 , PMID:21628964 mercury dichloride multiple interactions ISO RGD:1617617 6480464 [MT1 gene mutant form co-treated with MT2 gene mutant form co-treated with Mercuric Chloride] results in decreased abundance of Dopamine, [MT1 gene mutant form co-treated with MT2 gene mutant form] results in increased susceptibility to Mercuric Chloride CTD PMID:18226494 mercury dichloride affects expression EXP 6480464 Mercuric Chloride affects the expression of MT2A mRNA CTD PMID:10991963 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of MT2A mRNA CTD PMID:20229497 mercury dichloride multiple interactions EXP 6480464 Curcumin affects the reaction [Mercuric Chloride results in increased expression of MT2A mRNA] CTD PMID:20229497 mercury dichloride multiple interactions ISO RGD:1352146 6480464 Mercuric Chloride inhibits the reaction [Lipopolysaccharides results in increased expression of MT2A mRNA] CTD PMID:9138684 mercury(0) affects abundance ISO RGD:1352146 6480464 MT2A gene SNP affects the abundance of Mercury CTD PMID:22233731 mercury(0) affects response to substance ISO RGD:1352146 6480464 MT2A gene polymorphism affects the susceptibility to Mercury CTD PMID:23827881 mercury(0) increases expression EXP 6480464 Mercury results in increased expression of MT2A mRNA CTD PMID:2771874 more ... mercury(0) multiple interactions ISO RGD:1352146 6480464 [MT1M gene polymorphism co-treated with MT2A gene polymorphism] affects the susceptibility to Mercury CTD PMID:23827881 mercury(0) affects binding ISO RGD:1617617 6480464 Mercury binds to MT2 protein CTD PMID:15603537 mercury(0) increases expression ISO RGD:1617617 6480464 Mercury results in increased expression of MT2 mRNA, Mercury results in increased expression of MT2 protein CTD PMID:15138662 more ... mercury(0) increases response to substance ISO RGD:1617617 6480464 MT2 gene mutant form results in increased susceptibility to Mercury CTD PMID:15782327 mercury(0) multiple interactions ISO RGD:1617617 6480464 [MT1 co-treated with MT2] affects the susceptibility to Mercury, [MT3 protein affects the susceptibility to Mercury] which affects the expression of MT2 mRNA CTD PMID:22008530 , PMID:30103553 mesoporphyrin IX multiple interactions ISO RGD:1617617 6480464 [mesoporphyrin IX binds to HPX protein] which results in increased expression of MT2 mRNA, hexamethylene bisacetamide promotes the reaction [[mesoporphyrin IX binds to HPX protein] which results in increased expression of MT2 mRNA] CTD PMID:12042074 metformin affects expression EXP 6480464 Metformin affects the expression of MT2A mRNA CTD PMID:31324951 methamphetamine increases expression ISO RGD:1352146 6480464 Methamphetamine results in increased expression of MT2A mRNA CTD PMID:20801194 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of MT2A mRNA CTD PMID:15890375 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of MT2A mRNA CTD PMID:30467583 methidathion increases expression ISO RGD:1617617 6480464 methidathion results in increased expression of MT2 mRNA CTD PMID:34813904 methoxyacetic acid multiple interactions ISO RGD:1352146 6480464 methoxyacetic acid promotes the reaction [Promegestone results in increased expression of MT2A mRNA] CTD PMID:15103026 methoxychlor multiple interactions ISO RGD:1352146 6480464 MT2A protein inhibits the reaction [Methoxychlor results in decreased expression of HSD17B1 mRNA] CTD PMID:12858341 methyl methanesulfonate affects expression EXP 6480464 Methyl Methanesulfonate affects the expression of MT2A mRNA CTD PMID:12974610 methyl non-2-ynoate increases expression ISO RGD:1352146 6480464 2-nonynoic acid methyl ester results in increased expression of MT2A mRNA CTD PMID:20491607 methylmercury chloride increases expression ISO RGD:1617617 6480464 methylmercuric chloride results in increased expression of MT2 mRNA CTD PMID:21628964 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of MT2A mRNA CTD PMID:31378766 methylmercury chloride decreases expression ISO RGD:1617617 6480464 methylmercuric chloride results in decreased expression of MT2 mRNA CTD PMID:30103553 methylmercury chloride increases expression ISO RGD:1352146 6480464 methylmercuric chloride results in increased expression of MT2A mRNA CTD PMID:28001369 , PMID:32870474 microcystin-LR increases expression ISO RGD:1617617 6480464 cyanoginosin LR results in increased expression of MT2 mRNA CTD PMID:17654400 mono(2-ethylhexyl) phthalate affects expression ISO RGD:1617617 6480464 mono-(2-ethylhexyl)phthalate affects the expression of MT2 mRNA CTD PMID:21195148 Monobutylphthalate affects expression ISO RGD:1617617 6480464 monobutyl phthalate affects the expression of MT2 mRNA CTD PMID:21195148 motexafin gadolinium multiple interactions ISO RGD:1352146 6480464 motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of MT2A mRNA] CTD PMID:16357179 motexafin gadolinium increases expression ISO RGD:1352146 6480464 motexafin gadolinium results in increased expression of MT2A mRNA CTD PMID:15867382 , PMID:16357179 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions ISO RGD:1617617 6480464 N more ... CTD PMID:14617770 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions EXP 6480464 N more ... CTD PMID:23056475 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions ISO RGD:1352146 6480464 [N more ... CTD PMID:17018880 more ... N-(6-acetamidohexyl)acetamide multiple interactions ISO RGD:1617617 6480464 hexamethylene bisacetamide promotes the reaction [[cobaltiprotoporphyrin binds to HPX protein] which results in increased expression of MT2 mRNA], hexamethylene bisacetamide promotes the reaction [[mesoporphyrin IX binds to HPX protein] which results in increased expression of MT2 mRNA] CTD PMID:12042074 N-acetyl-L-cysteine multiple interactions ISO RGD:1352146 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of MT2A mRNA] more ... CTD PMID:18586083 more ... N-acetyl-L-cysteine decreases expression EXP 6480464 Acetylcysteine results in decreased expression of MT2A mRNA CTD PMID:33188856 N-acetyl-L-cysteine multiple interactions ISO RGD:1617617 6480464 [MT1 protein co-treated with MT2 protein] affects the reaction [Acetylcysteine affects the susceptibility to Doxorubicin] CTD PMID:20600803 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with hydroquinone] results in increased expression of MT2A mRNA] more ... CTD PMID:25724285 , PMID:33188856 N-methyl-4-phenylpyridinium increases expression ISO RGD:1352146 6480464 1-Methyl-4-phenylpyridinium results in increased expression of MT2A mRNA CTD PMID:32870474 N-nitrosodiethylamine increases expression ISO RGD:1352146 6480464 Diethylnitrosamine results in increased expression of MT2A mRNA CTD PMID:21527772 N-nitrosodiethylamine increases response to substance ISO RGD:1617617 6480464 MT2 gene mutant form results in increased susceptibility to Diethylnitrosamine CTD PMID:21159647 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of MT2A mRNA CTD PMID:15890375 , PMID:25380136 N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of MT2 mRNA CTD PMID:14600272 naphthalene increases expression ISO RGD:1617617 6480464 naphthalene results in increased expression of MT2 mRNA CTD PMID:18978301 nickel atom multiple interactions ISO RGD:1352146 6480464 Acetylcysteine inhibits the reaction [Nickel results in increased expression of MT2A mRNA] more ... CTD PMID:19097988 nickel atom increases expression ISO RGD:1352146 6480464 Nickel results in increased expression of MT2A mRNA, Nickel results in increased expression of MT2A protein CTD PMID:14971665 more ... nickel atom increases response to substance ISO RGD:1617617 6480464 MT2 gene mutant form results in increased susceptibility to Nickel CTD PMID:16166738 nickel atom decreases response to substance ISO RGD:1617617 6480464 MT2 protein results in decreased susceptibility to Nickel CTD PMID:16166738 nickel atom multiple interactions ISO RGD:1617617 6480464 MT2 affects the reaction [Nickel affects the expression of CALR3 mRNA] more ... CTD PMID:16166738 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of MT2A mRNA CTD PMID:22110744 nickel dichloride increases expression ISO RGD:1352146 6480464 nickel chloride results in increased expression of MT2A mRNA CTD PMID:26378417 , PMID:28472268 nickel sulfate increases expression ISO RGD:1352146 6480464 nickel sulfate results in increased expression of MT2A mRNA CTD PMID:16314067 , PMID:20491607 nickel sulfate increases expression ISO RGD:1617617 6480464 nickel sulfate results in increased expression of MT2 mRNA CTD PMID:16100012 , PMID:19131640 niclosamide increases expression ISO RGD:1352146 6480464 Niclosamide results in increased expression of MT2A mRNA CTD PMID:28284560 nicotine multiple interactions ISO RGD:1617617 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 nitric oxide multiple interactions ISO RGD:1617617 6480464 Nitric Oxide affects the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of MT2 mRNA] CTD PMID:14617770 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of MT2A mRNA CTD PMID:33484710 nitroprusside multiple interactions ISO RGD:1352146 6480464 [Nitroprusside results in increased abundance of nitrosonium ion] which results in increased expression of MT2A mRNA more ... CTD PMID:12393473 , PMID:17018880 nitroprusside increases expression ISO RGD:1352146 6480464 Nitroprusside results in increased expression of MT2A mRNA CTD PMID:17018880 ochratoxin A multiple interactions ISO RGD:1352146 6480464 [N more ... CTD PMID:19720134 , PMID:23391613 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of MT2A protein CTD PMID:24792326 ochratoxin A multiple interactions EXP 6480464 [MT1A protein co-treated with MT2A protein] inhibits the reaction [ochratoxin A results in decreased expression of MBP protein] CTD PMID:24792326 ochratoxin A increases expression ISO RGD:1352146 6480464 ochratoxin A results in increased expression of MT2A mRNA CTD PMID:19720134 , PMID:23391613 oleanolic acid increases expression EXP 6480464 Oleanolic Acid results in increased expression of MT2 mRNA more ... CTD PMID:17637929 , PMID:18706400 oleanolic acid increases expression ISO RGD:1617617 6480464 Oleanolic Acid results in increased expression of MT2 mRNA CTD PMID:17637929 , PMID:18706400 oleic acid multiple interactions EXP 6480464 [Oleic Acid co-treated with Palmitic Acid] results in increased expression of MT2A mRNA CTD PMID:26854922 organoselenium compound multiple interactions ISO RGD:1352146 6480464 [Organoselenium Compounds binds to Copper] which results in increased expression of MT2A mRNA CTD PMID:25167922 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of MT2A mRNA CTD PMID:25729387 oxaliplatin affects response to substance ISO RGD:1352146 6480464 MT2A protein affects the susceptibility to oxaliplatin CTD PMID:16773204 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of MT2A mRNA CTD PMID:25729387 oxaliplatin decreases expression ISO RGD:1352146 6480464 oxaliplatin results in decreased expression of MT2A mRNA CTD PMID:16773204 oxidopamine decreases response to substance EXP 6480464 MT2A protein results in decreased susceptibility to Oxidopamine CTD PMID:14604781 oxidopamine increases expression ISO RGD:1352146 6480464 Oxidopamine results in increased expression of MT2A mRNA CTD PMID:32870474 ozone multiple interactions EXP 6480464 [Ozone co-treated with Particulate Matter] results in increased expression of MT2A mRNA CTD PMID:23805001 ozone affects response to substance ISO RGD:1617617 6480464 MT2 protein affects the susceptibility to Ozone CTD PMID:18929643 ozone increases expression ISO RGD:1617617 6480464 Ozone results in increased expression of MT2 mRNA, Ozone results in increased expression of MT2 protein CTD PMID:12763052 more ... ozone multiple interactions ISO RGD:1617617 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MT2 mRNA more ... CTD PMID:18929643 more ... ozone increases expression EXP 6480464 Ozone results in increased expression of MT2A mRNA CTD PMID:23805001 more ... p-chloromercuribenzoic acid increases expression ISO RGD:1352146 6480464 p-Chloromercuribenzoic Acid results in increased expression of MT2A mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1352146 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MT2A mRNA CTD PMID:27188386 paclitaxel increases response to substance ISO RGD:1352146 6480464 MT2A mRNA results in increased susceptibility to Paclitaxel CTD PMID:16322897 paracetamol affects expression ISO RGD:1617617 6480464 Acetaminophen affects the expression of MT2 mRNA CTD PMID:15606129 , PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of MT2A mRNA CTD PMID:32479839 paracetamol multiple interactions ISO RGD:1617617 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of MT2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MT2 mRNA] CTD PMID:17585979 paracetamol increases expression ISO RGD:1617617 6480464 Acetaminophen results in increased expression of MT2 mRNA CTD PMID:11264010 paraquat increases expression ISO RGD:1352146 6480464 Paraquat results in increased expression of MT2A mRNA CTD PMID:14503839 , PMID:32870474 paraquat affects response to substance ISO RGD:1617617 6480464 MT2 protein affects the susceptibility to Paraquat CTD PMID:7890668 paraquat increases expression ISO RGD:1617617 6480464 Paraquat results in increased expression of MT2 mRNA CTD PMID:12595580 more ... paraquat multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in increased expression of MT2A mRNA]] more ... CTD PMID:20553223 , PMID:25724285 paraquat increases expression EXP 6480464 Paraquat results in increased expression of MT2A mRNA, Paraquat results in increased expression of MT2A protein CTD PMID:20553223 more ... parathion multiple interactions ISO RGD:1352146 6480464 [Parathion co-treated with Estradiol] results in decreased expression of MT2A mRNA CTD PMID:17982697 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1617617 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of MT2 mRNA CTD PMID:36331819 perfluorooctanoic acid multiple interactions ISO RGD:1617617 6480464 PPARA promotes the reaction [perfluorooctanoic acid results in increased expression of MT2 mRNA] CTD PMID:20118188 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of MT2A protein CTD PMID:34958885 perfluorooctanoic acid decreases expression ISO RGD:1617617 6480464 perfluorooctanoic acid results in decreased expression of MT2 mRNA CTD PMID:20118188 phenformin increases expression EXP 6480464 Phenformin results in increased expression of MT2A mRNA CTD PMID:31324951 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of MT2A mRNA CTD PMID:19162173 phenobarbital affects expression ISO RGD:1617617 6480464 Phenobarbital affects the expression of MT2 mRNA CTD PMID:23091169 phenobarbital decreases expression ISO RGD:1617617 6480464 Phenobarbital results in decreased expression of MT2 mRNA CTD PMID:19270015 , PMID:19850644 phenobarbital multiple interactions ISO RGD:1617617 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of MT2 mRNA], NR1I3 protein promotes the reaction [Phenobarbital results in decreased expression of MT2 mRNA] CTD PMID:19482888 , PMID:19850644 phenobarbital increases expression ISO RGD:1617617 6480464 Phenobarbital results in increased expression of MT2 mRNA CTD PMID:19482888 phenylmercury acetate increases expression ISO RGD:1352146 6480464 Phenylmercuric Acetate results in increased expression of MT2A mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1352146 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MT2A mRNA CTD PMID:27188386 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of MT2A mRNA CTD PMID:15215175 PhIP decreases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in decreased expression of MT2A mRNA CTD PMID:15215175 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1352146 6480464 [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of MT2A mRNA, BAG1 protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MT2A mRNA] CTD PMID:18958680 , PMID:20858459 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1617617 6480464 [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of MT2 mRNA CTD PMID:31904401 phorbol 13-acetate 12-myristate increases response to substance ISO RGD:1617617 6480464 MT2 results in increased susceptibility to Tetradecanoylphorbol Acetate CTD PMID:9506445 phorbol 13-acetate 12-myristate increases expression ISO RGD:1352146 6480464 Tetradecanoylphorbol Acetate results in increased expression of MT2A mRNA CTD PMID:20858459 phosgene affects expression ISO RGD:1617617 6480464 Phosgene affects the expression of MT2 mRNA CTD PMID:16300373 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of MT2A mRNA CTD PMID:15890375 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of MT2A mRNA CTD PMID:15890375 , PMID:19162173 pirinixic acid affects expression ISO RGD:1617617 6480464 pirinixic acid affects the expression of MT2 mRNA CTD PMID:11798191 , PMID:19850644 pirinixic acid multiple interactions ISO RGD:1617617 6480464 pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of MT2 mRNA] more ... CTD PMID:17321000 more ... pirinixic acid increases expression ISO RGD:1617617 6480464 pirinixic acid results in increased expression of MT2 mRNA CTD PMID:17426115 more ... pirinixic acid decreases expression ISO RGD:1617617 6480464 pirinixic acid results in decreased expression of MT2 mRNA CTD PMID:17321000 more ... piroxicam decreases expression ISO RGD:1352146 6480464 Piroxicam results in decreased expression of MT2A mRNA CTD PMID:21858171 platinum increases expression ISO RGD:1352146 6480464 Platinum results in increased expression of MT2A mRNA CTD PMID:28465190 platinum(0) increases expression ISO RGD:1352146 6480464 Platinum results in increased expression of MT2A mRNA CTD PMID:28465190 potassium bromate multiple interactions ISO RGD:1617617 6480464 vanillin inhibits the reaction [potassium bromate results in increased expression of MT2 mRNA] CTD PMID:27074584 potassium bromate increases expression ISO RGD:1617617 6480464 potassium bromate results in increased expression of MT2 mRNA CTD PMID:27074584 potassium dichromate decreases expression ISO RGD:1352146 6480464 Potassium Dichromate results in decreased expression of MT2A protein CTD PMID:23718831 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1617617 6480464 Pregnenolone Carbonitrile results in increased expression of MT2 mRNA CTD PMID:28903501 progesterone increases expression ISO RGD:1352146 6480464 Progesterone results in increased expression of MT2A mRNA CTD PMID:18037150 , PMID:21795739 progesterone increases expression ISO RGD:1617617 6480464 Progesterone results in increased expression of MT2 mRNA CTD PMID:22238285 progesterone affects expression ISO RGD:1617617 6480464 Progesterone affects the expression of MT2 mRNA CTD PMID:17251523 promegestone increases expression ISO RGD:1352146 6480464 Promegestone results in increased expression of MT2A mRNA CTD PMID:15103026 promegestone multiple interactions ISO RGD:1352146 6480464 methoxyacetic acid promotes the reaction [Promegestone results in increased expression of MT2A mRNA] CTD PMID:15103026 propiconazole increases expression ISO RGD:1617617 6480464 propiconazole results in increased expression of MT2 mRNA CTD PMID:22334560 prothioconazole increases expression ISO RGD:1352146 6480464 prothioconazole results in increased expression of MT2A mRNA CTD PMID:35048155 Ptaquiloside increases expression ISO RGD:1617617 6480464 ptaquiloside results in increased expression of MT2 mRNA, ptaquiloside results in increased expression of MT2 protein CTD PMID:23274088 purine-6-thiol increases expression EXP 6480464 Mercaptopurine results in increased expression of MT2A mRNA CTD PMID:23358152 quercetin affects expression EXP 6480464 Quercetin affects the expression of MT2A mRNA CTD PMID:18178720 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [glyphosate results in increased expression of MT2A mRNA], Quercetin promotes the reaction [Cadmium results in increased expression of MT2 mRNA] CTD PMID:16226777 , PMID:30821249 quercetin increases expression ISO RGD:1352146 6480464 Quercetin results in increased expression of MT2A mRNA CTD PMID:10656621 , PMID:21632981 raloxifene increases expression ISO RGD:1352146 6480464 Raloxifene Hydrochloride results in increased expression of MT2A mRNA CTD PMID:20945400 reactive oxygen species multiple interactions ISO RGD:1617617 6480464 [[[Cadmium Chloride results in increased abundance of Reactive Oxygen Species] results in increased activity of [MAPK1 protein co-treated with MAPK3 protein]] which results in increased phosphorylation of STAT3 protein] which results in increased expression of MT2 CTD PMID:23376140 reactive oxygen species multiple interactions ISO RGD:1352146 6480464 MT2A protein inhibits the reaction [Hydrogen Peroxide results in increased abundance of Reactive Oxygen Species] more ... CTD PMID:16402917 , PMID:19433272 reactive oxygen species affects degradation ISO RGD:1617617 6480464 MT2 protein affects the degradation of Reactive Oxygen Species CTD PMID:15639482 ritodrine increases expression ISO RGD:1617617 6480464 Ritodrine results in increased expression of MT2 mRNA CTD PMID:23370008 rotenone multiple interactions ISO RGD:1352146 6480464 MT2A protein inhibits the reaction [Rotenone results in increased abundance of Reactive Oxygen Species] more ... CTD PMID:16402917 rotenone decreases expression ISO RGD:1352146 6480464 Rotenone results in decreased expression of MT2A mRNA CTD PMID:36586010 rotenone affects expression EXP 6480464 Rotenone affects the expression of MT2A mRNA CTD PMID:28374803 rotenone increases expression EXP 6480464 Rotenone results in increased expression of MT2 mRNA CTD PMID:19818760 rotenone increases expression ISO RGD:1617617 6480464 Rotenone results in increased expression of MT2 mRNA CTD PMID:23186747 rotenone multiple interactions EXP 6480464 GPX4 protein inhibits the reaction [Rotenone results in increased expression of MT2 mRNA] CTD PMID:19818760 rotenone increases expression ISO RGD:1352146 6480464 Rotenone results in increased expression of MT2A mRNA CTD PMID:16402917 , PMID:32870474 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1352146 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of MT2A mRNA] CTD PMID:35811015 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions ISO RGD:1617617 6480464 [Buthionine Sulfoximine co-treated with Gefitinib] results in increased expression of MT2 mRNA CTD PMID:32741899 Salinomycin decreases expression ISO RGD:1352146 6480464 salinomycin results in decreased expression of MT2A mRNA CTD PMID:19682730 SB 431542 multiple interactions ISO RGD:1352146 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 senecionine increases expression ISO RGD:1617617 6480464 senecionine results in increased expression of MT2 mRNA CTD PMID:31606820 serotonin multiple interactions ISO RGD:1617617 6480464 [MT1 gene mutant form co-treated with MT2 gene mutant form] results in increased abundance of Serotonin CTD PMID:18226494 Shikonin multiple interactions ISO RGD:1617617 6480464 shikonin inhibits the reaction [Calcimycin results in increased expression of MT2 mRNA] CTD PMID:25451590 silicon dioxide increases expression ISO RGD:1617617 6480464 Silicon Dioxide results in increased expression of MT2 mRNA CTD PMID:23221170 , PMID:29203145 silver atom increases expression ISO RGD:1352146 6480464 Silver analog results in increased expression of MT2A mRNA, Silver results in increased expression of MT2A mRNA CTD PMID:22036727 more ... silver(0) increases expression ISO RGD:1352146 6480464 Silver analog results in increased expression of MT2A mRNA, Silver results in increased expression of MT2A mRNA CTD PMID:22036727 more ... silver(1+) nitrate increases expression ISO RGD:1617617 6480464 Silver Nitrate results in increased expression of MT2 mRNA CTD PMID:27624343 silver(1+) nitrate increases expression ISO RGD:1352146 6480464 Silver Nitrate results in increased expression of MT2A mRNA CTD PMID:10362023 more ... sodium arsenite multiple interactions ISO RGD:1617617 6480464 [Dietary Fats co-treated with sodium arsenite] results in increased expression of MT2 mRNA more ... CTD PMID:10924798 more ... sodium arsenite decreases expression ISO RGD:1352146 6480464 sodium arsenite results in decreased expression of MT2A mRNA CTD PMID:34032870 sodium arsenite multiple interactions EXP 6480464 [[sodium arsenite results in increased abundance of Arsenic] which co-treated with Zinc deficiency] results in increased expression of MT2A mRNA more ... CTD PMID:31542844 sodium arsenite increases expression ISO RGD:1352146 6480464 sodium arsenite results in increased expression of MT2A mRNA, sodium arsenite results in increased expression of MT2A protein CTD PMID:11693492 more ... sodium arsenite increases expression ISO RGD:1617617 6480464 sodium arsenite results in increased expression of MT2 mRNA CTD PMID:11525245 more ... sodium arsenite increases response to substance ISO RGD:1617617 6480464 MT2 gene mutant form results in increased susceptibility to sodium arsenite CTD PMID:25485709 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of MT2A mRNA CTD PMID:22110744 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of MT2A mRNA CTD PMID:25993096 sodium dichromate decreases expression ISO RGD:1617617 6480464 sodium bichromate results in decreased expression of MT2 mRNA CTD PMID:22155349 sodium dichromate increases expression ISO RGD:1617617 6480464 sodium bichromate results in increased expression of MT2 mRNA CTD PMID:22155349 sodium dodecyl sulfate increases expression ISO RGD:1352146 6480464 Sodium Dodecyl Sulfate results in increased expression of MT2A mRNA CTD PMID:31734321 streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of MT2A mRNA CTD PMID:24927960 SU6656 multiple interactions ISO RGD:1617617 6480464 [SU 6656 results in decreased activity of SRC protein] inhibits the reaction [Cadmium Chloride results in increased expression of MT2 protein] CTD PMID:23376140 succimer multiple interactions ISO RGD:1352146 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MT2A mRNA CTD PMID:26378955 sulforaphane increases expression ISO RGD:1617617 6480464 sulforaphane results in increased expression of MT2 mRNA CTD PMID:30529165 tamoxifen affects expression ISO RGD:1617617 6480464 Tamoxifen affects the expression of MT2 mRNA CTD PMID:20937368 temozolomide affects response to substance ISO RGD:1352146 6480464 MT2A mRNA affects the susceptibility to temozolomide CTD PMID:16365179 terbutaline multiple interactions ISO RGD:1352146 6480464 Terbutaline affects the reaction [Budesonide results in increased expression of MT2A mRNA] CTD PMID:9973176 tert-butyl hydroperoxide multiple interactions ISO RGD:1352146 6480464 MT2A protein inhibits the reaction [tert-Butylhydroperoxide results in increased abundance of Reactive Oxygen Species] more ... CTD PMID:16402917 , PMID:16636651 tert-butyl hydroperoxide affects response to substance ISO RGD:1617617 6480464 MT2 protein affects the susceptibility to tert-Butylhydroperoxide CTD PMID:7890668 tert-butyl hydroperoxide decreases response to substance ISO RGD:1617617 6480464 MT2 protein results in decreased susceptibility to tert-Butylhydroperoxide CTD PMID:16150881 tert-butyl hydroperoxide increases expression ISO RGD:1352146 6480464 tert-Butylhydroperoxide results in increased expression of MT2A mRNA CTD PMID:12414654 more ... tert-butyl hydroperoxide decreases response to substance ISO RGD:1352146 6480464 MT2A protein results in decreased susceptibility to tert-Butylhydroperoxide CTD PMID:16636651 tetrachloroethene increases expression ISO RGD:1617617 6480464 Tetrachloroethylene results in increased expression of MT2 mRNA CTD PMID:28973375 tetrachloromethane increases expression ISO RGD:1617617 6480464 Carbon Tetrachloride results in increased expression of MT2 mRNA, Carbon Tetrachloride results in increased expression of MT2 protein CTD PMID:20371262 more ... tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of MT2A mRNA CTD PMID:33387578 thapsigargin increases expression ISO RGD:1617617 6480464 Thapsigargin results in increased expression of MT2 mRNA CTD PMID:15019097 thifluzamide increases expression ISO RGD:1352146 6480464 thifluzamide results in increased expression of MT2A mRNA CTD PMID:33512557 thimerosal increases expression ISO RGD:1617617 6480464 Thimerosal results in increased expression of MT2 mRNA, Thimerosal results in increased expression of MT2 protein CTD PMID:19357975 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of MT2A mRNA CTD PMID:23411599 , PMID:34492290 thioacetamide affects response to substance ISO RGD:1617617 6480464 MT2 protein affects the susceptibility to Thioacetamide CTD PMID:15979673 thioacetamide increases expression ISO RGD:1617617 6480464 Thioacetamide results in increased expression of MT2 protein CTD PMID:15979673 titanium dioxide increases expression ISO RGD:1617617 6480464 titanium dioxide results in increased expression of MT2 mRNA CTD PMID:23557971 , PMID:27760801 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of MT2A mRNA CTD PMID:30012374 Tolmetin glucuronide increases expression ISO RGD:1352146 6480464 tolmetin glucuronide results in increased expression of MT2A mRNA CTD PMID:26528891 toluene decreases expression EXP 6480464 Toluene results in decreased expression of MT2A mRNA CTD PMID:22967744 topotecan increases expression EXP 6480464 Topotecan results in increased expression of MT2A mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of MT2A mRNA CTD PMID:25729387 triadimefon increases expression ISO RGD:1617617 6480464 triadimefon results in increased expression of MT2 mRNA CTD PMID:23970803 tributylstannane decreases expression ISO RGD:1617617 6480464 tributyltin results in decreased expression of MT2 mRNA CTD PMID:31939706 triclosan increases expression ISO RGD:1352146 6480464 Triclosan results in increased expression of MT2A mRNA CTD PMID:30510588 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of MT2A mRNA CTD PMID:30589522 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1352146 6480464 tris(2-butoxyethyl) phosphate affects the expression of MT2A mRNA CTD PMID:29024780 troglitazone increases expression ISO RGD:1352146 6480464 troglitazone results in increased expression of MT2A mRNA CTD PMID:19631733 trovafloxacin multiple interactions ISO RGD:1617617 6480464 [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of MT1E mRNA CTD PMID:18930950 trovafloxacin decreases expression ISO RGD:1617617 6480464 trovafloxacin results in decreased expression of MT2 mRNA CTD PMID:35537566 tunicamycin increases expression ISO RGD:1617617 6480464 Tunicamycin results in increased expression of MT2 mRNA CTD PMID:15019097 , PMID:17127020 tunicamycin decreases expression ISO RGD:1352146 6480464 Tunicamycin results in decreased expression of MT2A mRNA CTD PMID:36586010 tunicamycin multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [MT2A protein inhibits the reaction [Tunicamycin results in decreased phosphorylation of AKT1 protein]] CTD PMID:24680926 tunicamycin multiple interactions ISO RGD:1352146 6480464 MT2A protein inhibits the reaction [Tunicamycin results in decreased phosphorylation of AKT1 protein] more ... CTD PMID:24680926 tyrphostin AG 1478 multiple interactions ISO RGD:1617617 6480464 [RTKI cpd results in decreased activity of EGFR protein] inhibits the reaction [Cadmium Chloride results in increased expression of MT2 protein] CTD PMID:23376140 uranium atom increases expression ISO RGD:1352146 6480464 Uranium results in increased expression of MT2A mRNA CTD PMID:14971665 urethane increases expression ISO RGD:1352146 6480464 Urethane results in increased expression of MT2A mRNA CTD PMID:28818685 ursodeoxycholic acid increases expression EXP 6480464 Ursodeoxycholic Acid results in increased expression of MT2A mRNA CTD PMID:10491327 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of MT2A mRNA CTD PMID:23665938 valproic acid multiple interactions ISO RGD:1352146 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MT2A mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1352146 6480464 Valproic Acid results in increased expression of MT2A mRNA CTD PMID:19101580 more ... valproic acid affects expression ISO RGD:1352146 6480464 Valproic Acid affects the expression of MT2A mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1617617 6480464 Valproic Acid results in increased expression of MT2 mRNA CTD PMID:15345369 , PMID:19136453 vancomycin decreases expression ISO RGD:1617617 6480464 Vancomycin results in decreased expression of MT2 mRNA CTD PMID:18930951 vanillin increases expression ISO RGD:1352146 6480464 vanillin results in increased expression of MT2A mRNA CTD PMID:20491607 vanillin multiple interactions ISO RGD:1617617 6480464 vanillin inhibits the reaction [potassium bromate results in increased expression of MT2 mRNA] CTD PMID:27074584 vincristine increases expression ISO RGD:1352146 6480464 Vincristine results in increased expression of MT2A mRNA CTD PMID:23649840 water multiple interactions ISO RGD:1617617 6480464 [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which affects the expression of MT2 mRNA CTD PMID:29335169 zidovudine multiple interactions ISO RGD:1352146 6480464 [Zidovudine co-treated with IFNA1 protein] results in increased expression of MT2A mRNA CTD PMID:20370541 zinc acetate increases expression ISO RGD:1617617 6480464 Zinc Acetate results in increased expression of MT2 mRNA, Zinc Acetate results in increased expression of MT2 protein CTD PMID:15306638 , PMID:8876661 zinc acetate increases expression ISO RGD:1352146 6480464 Zinc Acetate results in increased expression of MT2A mRNA CTD PMID:16357179 zinc acetate multiple interactions ISO RGD:1352146 6480464 motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of MT2A mRNA] CTD PMID:16357179 zinc atom multiple interactions ISO RGD:1352146 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Zinc results in increased expression of MT2A mRNA] more ... CTD PMID:12716893 more ... zinc atom increases expression ISO RGD:1352146 6480464 Zinc results in increased expression of MT2A mRNA CTD PMID:11127411 more ... zinc atom increases expression ISO RGD:1617617 6480464 Zinc results in increased expression of MT2 mRNA CTD PMID:10605938 more ... zinc atom affects binding ISO RGD:1617617 6480464 Zinc binds to MT2 protein CTD PMID:16987576 zinc atom affects transport ISO RGD:1617617 6480464 MT2 protein affects the transport of Zinc CTD PMID:23274088 zinc atom multiple interactions ISO RGD:1617617 6480464 [MT1 protein co-treated with MT2 protein] inhibits the reaction [SLC30A1 gene mutant form results in increased susceptibility to Zinc] more ... CTD PMID:14617770 more ... zinc atom multiple interactions EXP 6480464 [[sodium arsenite results in increased abundance of Arsenic] which co-treated with Zinc deficiency] results in increased expression of MT2A mRNA more ... CTD PMID:15041749 more ... zinc atom increases expression EXP 6480464 Zinc deficiency results in increased expression of MT2A more ... CTD PMID:12672911 more ... zinc atom affects binding ISO RGD:1352146 6480464 Zinc binds to MT2A protein CTD PMID:15698955 , PMID:17224279 zinc atom affects expression EXP 6480464 Zinc affects the expression of MT2A mRNA CTD PMID:14690761 zinc dichloride multiple interactions ISO RGD:1352146 6480464 [zinc chloride co-treated with pyrithione zinc] results in increased expression of MT2A mRNA more ... CTD PMID:17234632 more ... zinc dichloride multiple interactions ISO RGD:1617617 6480464 zinc chloride promotes the reaction [Cadmium Chloride results in increased expression of MT2 mRNA] CTD PMID:16842966 zinc dichloride affects binding ISO RGD:1617617 6480464 zinc chloride binds to MT2 protein CTD PMID:16987576 zinc dichloride affects response to substance ISO RGD:1617617 6480464 MT2 affects the susceptibility to zinc chloride CTD PMID:19835899 zinc dichloride increases expression ISO RGD:1617617 6480464 zinc chloride results in increased expression of MT2 mRNA, zinc chloride results in increased expression of MT2 protein CTD PMID:15288509 more ... zinc dichloride increases expression EXP 6480464 zinc chloride results in increased expression of MT2A mRNA, zinc chloride results in increased expression of MT2A protein CTD PMID:17637929 zinc dichloride multiple interactions EXP 6480464 zinc chloride promotes the reaction [Glucose results in increased expression of MT2A mRNA] CTD PMID:23056475 zinc dichloride increases expression ISO RGD:1352146 6480464 zinc chloride results in increased expression of MT2A mRNA CTD PMID:16870260 more ... zinc molecular entity increases expression ISO RGD:1352146 6480464 Zinc Compounds results in increased expression of MT2A mRNA CTD PMID:24035972 zinc pyrithione increases expression ISO RGD:1352146 6480464 pyrithione zinc results in increased expression of MT2A mRNA, pyrithione zinc results in increased expression of MT2A protein CTD PMID:20151177 , PMID:21424779 zinc pyrithione multiple interactions ISO RGD:1352146 6480464 [zinc chloride co-treated with pyrithione zinc] results in increased expression of MT2A mRNA CTD PMID:20801194 zinc sulfate multiple interactions ISO RGD:1352146 6480464 [Zinc Sulfate results in increased abundance of Zinc] which results in increased expression of MT2A mRNA more ... CTD PMID:12566070 more ... zinc sulfate increases expression ISO RGD:1617617 6480464 Zinc Sulfate results in increased expression of MT2 mRNA CTD PMID:26763393 zinc sulfate increases expression EXP 6480464 Zinc Sulfate results in increased expression of MT2A mRNA, Zinc Sulfate results in increased expression of MT2A protein CTD PMID:17241390 more ... zinc sulfate multiple interactions EXP 6480464 [Zinc Sulfate co-treated with ferrous sulfate] results in increased expression of and affects the localization of MT2A protein more ... CTD PMID:17241390 more ... zinc sulfate increases expression ISO RGD:1352146 6480464 Zinc Sulfate results in increased expression of MT2A mRNA CTD PMID:10362023 more ... zinc(0) increases expression EXP 6480464 Zinc deficiency results in increased expression of MT2A more ... CTD PMID:12672911 more ... zinc(0) multiple interactions ISO RGD:1352146 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Zinc results in increased expression of MT2A mRNA] more ... CTD PMID:12716893 more ... zinc(0) multiple interactions EXP 6480464 [[sodium arsenite results in increased abundance of Arsenic] which co-treated with Zinc deficiency] results in increased expression of MT2A mRNA more ... CTD PMID:15041749 more ... zinc(0) affects binding ISO RGD:1352146 6480464 Zinc binds to MT2A protein CTD PMID:15698955 , PMID:17224279 zinc(0) affects expression EXP 6480464 Zinc affects the expression of MT2A mRNA CTD PMID:14690761 zinc(0) multiple interactions ISO RGD:1617617 6480464 [MT1 protein co-treated with MT2 protein] inhibits the reaction [SLC30A1 gene mutant form results in increased susceptibility to Zinc] more ... CTD PMID:14617770 more ... zinc(0) affects transport ISO RGD:1617617 6480464 MT2 protein affects the transport of Zinc CTD PMID:23274088 zinc(0) affects binding ISO RGD:1617617 6480464 Zinc binds to MT2 protein CTD PMID:16987576 zinc(0) increases expression ISO RGD:1617617 6480464 Zinc results in increased expression of MT2 mRNA CTD PMID:10605938 more ... zinc(0) increases expression ISO RGD:1352146 6480464 Zinc results in increased expression of MT2A mRNA CTD PMID:11127411 more ... ziram increases expression ISO RGD:1352146 6480464 Ziram results in increased expression of MT2A mRNA CTD PMID:32870474 zoledronic acid increases expression ISO RGD:1352146 6480464 zoledronic acid results in increased expression of MT2A mRNA CTD PMID:24714768 , PMID:25596134
